🇺🇸 FDA
Patent

US 7862815

Methods for inhibiting angiogenesis with inhibitors of proadrenomedullin N-terminal 20 peptide (PAMP)

granted A61KA61K38/00A61K38/1825

Quick answer

US patent 7862815 (Methods for inhibiting angiogenesis with inhibitors of proadrenomedullin N-terminal 20 peptide (PAMP)) held by The United States of America, as represented by the Department of Health and Human Services expires Mon Dec 30 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Department of Health and Human Services
Grant date
Tue Jan 04 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 30 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
13
CPC classes
A61K, A61K38/00, A61K38/1825, A61K38/1866, A61P